NCT00300040View on ClinicalTrials.gov

Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia

PHASE2TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Peripheral Vascular Disease
Interventions
DRUG

Hemoglobin glutamer 250 - bovine

intravenous - 250ml/dose - 32.5g Hb (Concentration 13 +/- 1g/dL)

DRUG

6% Hydroxyethylstarch

250ml for intravenous infusion

Trial Locations (5)

2041

Johannesburg Hospital, Johannesburg

2193

Milpark Hospital, Parktown West

7506

University of Stellenbosch, Tygerburg

0001

Pretoria Academic Hospital, Pretoria

OX3 9DU

John Radcliffe Hospital, Headington

Sponsors
All Listed Sponsors
lead

Biopure Corporation

INDUSTRY